Cardiology GPSI Dr Matt Hughes outlines five key recent developments and their impact on GP practice including NICE hypertension guidance, new anticoagulants for stroke prevention, generic atorvastatin and new data on exercise referral.
To give a GP focused update on five important developments in the area of cardiology:
Latest NICE guidance on hypertension
Doubts over the value of exercise referral
Dabigatran and rivaroxaban as alternatives to warfarin in patients with atrial filbrillation
The implications of generic versions of atorvastatin
The four big unanswered questions on hypertension as identified by the European Society of Cardiology
This module is free for all registered members of Pulse Learning until 27 June 2012.